CompletedNCT00280566
This study is completed. It focuses on bipolarity and currently lists study information in Chile, France, Germany, Guatemala, China, India, Italy, Mexico, Russian Federation, Spain, Taiwan, the United States, and Venezuela.
Multiple locations, including BirminghamBipolarityOtherOver 18 Years
- Countries
- United States, France, Chile, ...
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
TerminatedNCT01122927
This study was terminated in the United States, in Bulgaria, in Croatia, .... It is testing aripiprazole for schizophrenia.
Multiple locations, including DothanBipolarity, SchizophreniaOtherFrom 10 Years to 17 Years
- Countries
- United States, Bulgaria, Croatia, ...
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Bipolarity, Schizophrenia
WithdrawnNCT01124877
This study was withdrawn in Global. It is testing flexible Doses Of Oral Ziprasidone for Bipolarity.
In GlobalBipolarityOtherFrom 10 Years to 17 Years
- Countries
- Global
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT00265330
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
Multiple locations, including ScottsdaleBipolarityOtherFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT00490542
This study is completed. It focuses on depression and currently lists study information in the United States.
Multiple locations, including ChicagoDepression, BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Tufts Medical Center
- Condition
- Depression, Bipolarity
CompletedNCT00908154
This study is completed in the United Kingdom. It focuses on Bipolarity.
In LondonBipolarity, DepressionOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- Biogen
- Condition
- Bipolarity, Depression
CompletedNCT01396447
This study is completed in the United States, in Canada, in Bulgaria, .... It is testing safety, Tolerability, and Efficacy of Cariprazine in Participants With Depression for depression in bipolarity.
Multiple locations, including BirminghamBipolarity, DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States, Canada, Bulgaria, ...
- Sponsor
- Forest Laboratories
- Condition
- Bipolarity, Depression
TerminatedNCT03210480
This study has public registry information. It focuses on bipolarity and currently lists study information in Italy.
Multiple locations, including OrbetelloBipolarityOtherFrom 18 Years to 65 Years
- Countries
- Italy
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Condition
- Bipolarity
CompletedNCT03158805
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In MasonBipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Lindner Center of HOPE
- Condition
- Bipolarity
CompletedNCT04211961
This study is completed. It focuses on bipolarity and currently lists study information in Ireland.
In GalwayBipolarity, DepressionOtherOver 18 Years
- Countries
- Ireland
- Sponsor
- Dr. Brian Hallahan
- Condition
- Bipolarity, Depression
UnknownNCT06282250
This study has public registry information. It focuses on bipolarity and currently lists study information in the Netherlands.
In EindhovenBipolarityBehavioralFrom 16 Years to 35 Years
- Countries
- Netherlands
- Sponsor
- Geestelijke Gezondheidszorg Eindhoven (GGzE)
- Condition
- Bipolarity
CompletedNCT04436757
This study is completed. It focuses on depression and currently lists study information in France.
In LyonDepression, Schizophrenia, ...OtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Depression, Schizophrenia, ...